Federal · Amendment
Dealer's licence fee rules updated to reference the Controlled Substances Regulations instead of older drug regulations
Fees in Respect of Dealer’s Licences Regulations — under the FINANCIAL ADMINISTRATION ACT
Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.
Plain-language summary · AI-assisted
Amendments previously listed as 'not in force' have now been incorporated into the consolidated text of the Fees in Respect of Dealer's Licences Regulations. The key practical change is that the rules now explicitly reference the Controlled Substances Regulations as the governing framework for dealer's licences, replacing references to the older Food and Drug Regulations and Narcotic Control Regulations. A new definitions section (section 1) has been added to the main body of the regulations, defining 'dealer's licence' and 'health care facility' in line with the Controlled Substances Regulations. The former definitions section (section 29) has been repealed, and the fee-payment timing provision now directs applicants to sections 11 and 15 of the Controlled Substances Regulations. Businesses holding or applying for a dealer's licence for controlled drugs or narcotics should ensure their compliance processes and application submissions align with the Controlled Substances Regulations rather than the older rules.
Who this affects
holders of dealer's licences for controlled drugs or narcotics · applicants for dealer's licence issuance or renewal · health care facilities licensed to handle controlled substances · businesses conducting activities under dealer's licences
Check the official text
SOR/2011-79 on the official source ↗
This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.